Risk stratification of necrotizing fasciitis based on the initial procalcitonin concentration: A single center observational study

Surgical Infections

Volumn 16, Issue 6, 2015, Pages 806-812

  Al Thani, Hassan ^a   El Menyar, Ayman ^a,b   Shaikh, Nissar ^a   Mudali, Insolvisagan Natesa ^a   Mekkodathil, Ahammed ^a   Asim, Mohammad ^a   Gameil, Amna ^a   Tabeb, Abdelhakem ^a  

^a HAMAD GENERAL HOSPITAL   (Qatar)

^b WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; PROCALCITONIN; CALCITONIN; PROTEIN PRECURSOR;

ABDOMEN; ADULT; AREA UNDER THE CURVE; ARTICLE; CHEST INFECTION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HORMONE BLOOD LEVEL; HUMAN; INFECTION RISK; INTENSIVE CARE; LEG; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; NECROTIZING FASCIITIS; PATIENT CODING; PERINEUM; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; THIGH; AGED; BLOOD; COMPLICATION; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; CALCITONIN; FASCIITIS, NECROTIZING; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEPSIS;

EID: 84948679036     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2014.249     Document Type: Article

References (29)

1. Taviloglu K, Yanar H. Necrotizing fasciitis: Strategies for diagnosis and management. World J Emerg Surg 2007;2:19.
2. Roje Z, Roje Z,Matic D, et al.Necrotizing fasciitis: Literature review of contemporary strategies for diagnosing and managementwith three case reports: Torso, abdominalwall, upper and lower limbs. World J Emerg Surg 2011;6:46
3. Reinhart K, Daniels R, Kissoon N, et al. The burden of sepsis-a call to action in support of World Sepsis Day 2013. J Crit Care 2013;28:526-528.
4. El-Menyar A, Al-Thani H, Latifi R, et al. Multiple Organ Dysfunction Syndrome (MODS): Is it preventable or inevitable?. Int J Clin Med 2012;3:722-730. doi: 10.4236/ ijcm.2012.37A127
5. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006;34:344-353.
6. Hall MJ,Williams SN,DeFrances CJ,Golosinskiy A. Inpatient care for septicemia or sepsis: A challenge for patients and hospitals. NCHS Data Brief 2011;(62):1-8.
7. Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis. Lancet Infect Dis 2013;13:426-435.
8. Nargis W, Ibrahim M, Ahamed BU.Procalcitonin versus Creactive protein: Usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci 2014;4:195-199.
9. Chiesa C, Panero A, Rossi N, et al. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 1998;26:664-672.
10. Chiesa C, Pellegrini G, Panero A, et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: Influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 2003;49:60-68
11. Joram N, Muller JB, Denizot S, et al. Umbilical cord blood procalcitonin level in early neonatal infections: A 4-year university hospital cohort study. Eur J Clin Microbiol Infect Dis 2011;30:1005-1013.
12. Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: A tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 2004;32:1535-1541.
13. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsisrelated Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22: 707-710.
14. Marik PE, Lipman J. The definition of septic shock: Implications for treatment. Crit Care Resusc 2007;9:101-103.
15. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36
16. Kao LS, Lew DF, Arab SN, et al. Local variations in the epidemiology, microbiology, and outcome of necrotizing soft-tissue infections: A multicenter study. Am J Surg 2011; 202:139-145.
17. Herr M, Grabein B, Palm HG, et al. [Necrotizing fasciitis. 2011 update]. Unfallchirurg 2011;114:197-216.
18. Malangoni MA. Necrotizing soft tissue infections: Are we making any progress? Surg Infect 200;2:145-150.
19. Chesney RW, McCarron DM, Haddad JG, et al. Pathogenic mechanisms of the hypocalcemia of the staphylococcal toxic-shock syndrome. J Lab Clin Med 1983;101: 576-585.
20. Nelson GE, Mave V, Gupta A. Biomarkers for sepsis: A review with special attention to India. Biomed Res Int 2014;2014:264351.
21. Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-518.
22. Park IH, Lee SH, Yu ST, et al. Serum procalcitonin as a diagnostic marker of neonatal sepsis. Korean J Pediatr 2014;57:451-456
23. Sitter T, Schmidt M, Schneider S, et al. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin. J Nephrol 2002;15:297-301.
24. Delevaux I, Andre M, Colombier M, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 2003;62:337-340.
25. Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin Infect Dis 2004;39:206-217
26. Holub M, Rozsypal H, Chalupa P. [Procalcitonin: a reliable marker for the diagnosis and monitoring of the course of bacterial infection]. KlinMikrobiolInfekcLek 2008;14:201-208.
27. Tamaki K, Kogata Y, Sugiyama D, et al. Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases. J Rheumatol 2008;35:114-119.
28. Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001;286:1754-1758.
29. Sudhir U, Venkatachalaiah RK, Kumar TA, et al. Significance of serum procalcitonin in sepsis. Indian J Crit Care Med 2011;15:1-5.